Nasdaq agrx.

Founded in 1993 in Alexandria, VA., by brothers David and Tom Gardner, The Motley Fool is a multimedia financial-services company dedicated to building the world's …

Nasdaq agrx. Things To Know About Nasdaq agrx.

Insider Monkey Transcripts. Agile Therapeutics, Inc. (NASDAQ: AGRX) Q3 2023 Earnings Call Transcript November 9, 2023. Agile Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-1.58. Operator: Good morning, and welcome to the Agile Therapeutics Third Quarter 2023 Financial Results Conference Call.Agile Thrpe stock price live 2.1400, this page displays NASDAQ AGRX stock exchange data. View the AGRX premarket stock price ahead of the market session or assess the after hours quote.PRINCETON, N.J., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that it has received a response from FDA’s Office of ...View real-time AGRX stock price and news, along with industry-best analysis. ... Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet, Dow Jones. ETF Movers: Includes ETFs & ETNs with ...

Agile Therapeutics Inc (NASDAQ:AGRX) is not the least popular stock in this group but hedge fund interest is still below average. Our overall hedge fund sentiment score for AGRX is 35.8.PRINCETON, N.J., May 22, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced the pricing of its ...The latest price target for Agile Therapeutics ( NASDAQ: AGRX) was reported by Maxim Group on Friday, September 22, 2023. The analyst firm set a price target for 5.00 expecting AGRX to rise to ...

PRINCETON, N.J., Jan. 02, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the appointment of Kimberly Whelan as Vice President of ...The new research reports from Fundamental Markets, available for free download at the links above, examine Halozyme Therapeutics, Inc. (NASDAQ:HALO), Capricor Therapeutics, Inc. (NASDAQ:CAPR ...

NASDAQ: AGRX · IEX Real-Time Price · USD. Add to Watchlist 2.16 +0.09 (4.35%) Dec 1, 2023, 4:00 PM EST - Market closed. Overview; Financials; ... Stock Price Forecast. According to 2 stock analysts, the average 12-month stock price forecast for AGRX stock stock is $8.50, which predicts an increase of 293.52%. The lowest target is …PRINCETON, N.J., Jan. 02, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the appointment of Kimberly Whelan as Vice President of ...View live Agile Therapeutics, Inc. chart to track its stock's price action. Find market predictions, AGRX financials and market news.Sep 27, 2023 · Maxim Group, a major investment bank, conducts and publishes stock analysis through its Equity Research team. The team has a strong reputation in the industry; a host of major firms use its ... Le cours de l'action AGILE THERAPEUT AGRX sur Boursorama : historique de la cotation sur NASDAQ, graphique, actualités, consensus des analystes et ...

Apr 9, 2021 · On Mar. 31, he reported buying 10,000 shares at an average price of $20.17. This case of insider buying is a personal investment of over $200,000. Wall Street also thinks that the shares are ...

Stock analysis for Agile Therapeutics Inc (AGRX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

PRINCETON, N.J., June 24, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that a meeting of the Bone, Reproductive and Urologic ...... Therapeutics Inc (AGRX). Agile Therapeutics Inc (AGRX). 2.16 +0.05 (+2.37%) 12/01/23 [NASDAQ]. N/A x N/A N/A x N/A. Realtime by (Cboe BZX). N/A x N/A N/A x N/A.Agile Therapeutics, Inc. Common Stock (AGRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. AGRX Latest Real Time Trades ... Add symbols now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing stocks, funds and ETFs, and more asset classes. /AGRX tried to move up and failed, broke the support level yesterday, and is now trading below it. Our idea is to take AGRX if it breaks the $ 1.97 price for further dec Hi traders, The consumer sector has been in a sharp decline in recent days and we have a trading idea in AGRX for further declines. AGRX tried to move up and failed, broke the ...

The new research reports from Fundamental Markets, available for free download at the links above, examine Halozyme Therapeutics, Inc. (NASDAQ:HALO), Capricor Therapeutics, Inc. (NASDAQ:CAPR ...The Company’s common stock will open for trading on the Nasdaq Market on Wednesday, April 27, 2022 on a split-adjusted basis under the current trading symbol "AGRX."Agile Therapeutics, Inc. Common Stock (AGRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Find the latest Financials data for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com. Agile Therapeutics, Inc. (NASDAQ:AGRX) Q4 2022 Earnings Call Transcript (Insider Monkey) Mar-23-23 12:49PM Q4 2022 Agile Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)-9.33%. Mar-22-23 04:05PM Agile Therapeutics Reports Fourth Quarter & Full Year 2022 Financial Results and Provides Corporate Update ...The new research reports from Fundamental Markets, available for free download at the links above, examine AK Steel Holding Corporation (NYSE:AKS), BioTelemetry, Inc. (NASDAQ:BEAT), MarineMax, Inc ...

15 Jun 2023 ... Agile's Capital Raise Strategies In A Competitive Market: NASDAQ: $AGRX CEO Al Altomari's Approach. 80 views · 2 months ago #WomensHealth #AGRX

Maxim Group, a major investment bank, conducts and publishes stock analysis through its Equity Research team. The team has a strong reputation in the industry; a host of major firms use its ...Agile Therapeutics Stock (NASDAQ:AGRX), Quotes and News Summary · Agile Therapeutics Posts Growth In Third Quarter Results, Reiterates Confidence In Target of ...AGRX tried to move up and failed, broke the support level yesterday, and is now trading below it. Our idea is to take AGRX if it breaks the $ 1.97 price for further dec Hi traders, The consumer sector has been in a sharp decline in recent days and we have a trading idea in AGRX for further declines. AGRX tried to move up and failed, broke the ...Agile Therapeutics, Inc. (NASDAQ:AGRX) is a New Jersey-based healthcare company focused on catering to the unmet demands of women by offering them various contraceptive options.Agile Therapeutics (NASDAQ: AGRX), a women's healthcare company, reported increasing Twirla prescription data for the first quarter 2022.Twirla cycles dispensed increased 29% to 16,602; Total ...Agile Therapeutics Inc. (NASDAQ: AGRX) Avadel Pharmaceuticals Plc (NASDAQ: AVDL) Venator Materials Plc Agile Therapeutics Inc. (NASDAQ: AGRX) Agile Therapeutics is one of the bigger gainers so far today with over 19% in gains during morning trading. This comes after a five day and one month drop of more than 19% and over 45%.PRINCETON, N.J., July 08, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Chairman and CEO Al Altomari will be participating in ...Real time Agile Therapeutics (AGRX) stock price quote, stock graph, news & analysis. Find the latest Earnings Report Date for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com.PRINCETON, N.J., April 07, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that data from the company’s first-year of ...

18 Feb 2020 ... Agile Therapeutics Inc (NASDAQ:AGRX) announced Tuesday that the US Food and Drug Administration (FDA) has approved Twirla, a new non-daily ...

Agile Therapeutics Inc Follow Share $2.06 Nov 27, 1:01:11 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to Amarin Corporation plc $0.76 AMRN2.89% Apple Inc $190.63 AAPL0.34% Actinium...

AGRX earnings call for the period ending June 30, 2022. Image source: The Motley Fool. Agile Therapeutics ( AGRX 1.60%) Q2 2022 Earnings Call. Aug 11, 2022, 4:30 p.m. ET.If you would like to register as a market maker in AGRX, contact Nasdaq Trading Operations at +1 212 231 5100. Email Alert Subscriptions: Nasdaq offers customers the ability to self select news delivery across various Nasdaq markets.PRINCETON, N.J., March 15, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq: AGRX), a women's healthcare company, today announced that an abstract presenting data from two Phase 1 in ...Shares of NASDAQ AGRX opened at $2.16 on Friday. The firm has a market capitalization of $5.42 million, a PE ratio of -0.16 and a beta of 1.81. The firm’s 50-day moving average is $1.99 and its ...PRINCETON, N.J., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a forward-thinking women’s healthcare company, today announced the pricing of its underwritten public ...The extension notice from Nasdaq has no immediate effect on the listing or trading of the Company’s shares, which will continue to trade on the Nasdaq Capital Market under the symbol “AGRX.”PRINCETON, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced Chairman and Chief Executive Officer Al Altomari will ...PRINCETON, N.J., April 14, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced Twirla prescription data for the first quarter 2022.PRINCETON, N.J., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that it has received a response from FDA’s Office of ...Apr 9, 2021 · On Mar. 31, he reported buying 10,000 shares at an average price of $20.17. This case of insider buying is a personal investment of over $200,000. Wall Street also thinks that the shares are ... Created with Sketch. when trading, helping you to optimize your price and have a successful order execution. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4 ... Agile Therapeutics Inc (NASDAQ:AGRX) Agile Therapeutics Inc. 1.90. Delayed Data. As of Nov 14. -0.02 / -1.04%. Today’s Change. 1.65. Today ||| 52-Week Range.

PRINCETON, N.J., June 24, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that a meeting of the Bone, Reproductive and Urologic ...PRINCETON, N.J., July 12, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, announced that it has updated its second quarter 2022 Twirla demand (total ...PRINCETON, N.J., July 12, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, announced that it has updated its second quarter 2022 Twirla demand (total ...Find the latest Revenue & EPS data for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com.Instagram:https://instagram. chicken soup for the soul stockcarvana car priceskaryopharm therapeuticsnasdaq sovo PRINCETON, N.J., April 30, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that a post hoc analysis of the Phase 3 SECURE Trial ... nasdaq zitlsa The extension notice from Nasdaq has no immediate effect on the listing or trading of the Company’s shares, which will continue to trade on the Nasdaq Capital Market under the symbol “AGRX.” dhhorton Nov 14, 2021 · Agile Therapeutics, Inc. (Agile or the Company) (NasdaqCM: NASDAQ: AGRX) is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Agile ... PRINCETON, N.J., June 24, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that a meeting of the Bone, Reproductive and Urologic ...AGRX has an Altman Z-Score of -49.72 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy. Detailed statistics for Agile Therapeutics, Inc. (AGRX) stock, including valuation metrics, financial numbers, share information and more.